Literature DB >> 2077541

Distribution of lipid microspheres incorporating prostaglandin E1 to vascular lesions.

Y Mizushima1, T Hamano, S Haramoto, S Kiyokawa, A Yanagawa, K Nakura, M Shintome, M Watanabe.   

Abstract

The intravascular distribution of 0.2 mu lipid microspheres (LM) containing prostaglandin E1 (lipo-PGE1) injected intravenously in spontaneously hypertensive rats (SHR) and arteriosclerotic rabbits was investigated by electron microscopic observation and quantification of radiolabelled compounds. LM were observed under an electron microscope to concentrate in subendothelial space of vascular walls, particularly in vascular lesions associated with hypertension or arteriosclerosis. Radiolabelled lipo-PGE1 accumulated more densely in the vascular walls than did free PGE1, and the difference was more conspicuous in vascular lesions. This indicates that lipo-PGE1 penetrates vascular endothelium and then accumulates in blood vessels to result in augmentation of the pharmacological action of prostaglandin. These findings suggest the usefulness of LM as a carrier of prostaglandin to vascular lesions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2077541     DOI: 10.1016/0952-3278(90)90141-7

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  5 in total

1.  Prolonging the in vivo residence time of prostaglandin E(1) with biodegradable nanoparticles.

Authors:  Tsutomu Ishihara; Miyuki Takahashi; Megumu Higaki; Mitsuko Takenaga; Tohru Mizushima; Yutaka Mizushima
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200

2.  Aneurysmal dilatation of ductus arteriosus during lipo-prostaglandin E1 therapy for diaphragmatic hernia.

Authors:  M Tohyama; A Baba; T Tsuno; K Aonuma; A Komiyama
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

3.  Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles.

Authors:  Tsutomu Ishihara; Miho Takeda; Haruka Sakamoto; Ayumi Kimoto; Chisa Kobayashi; Naoko Takasaki; Kanae Yuki; Ken-ichiro Tanaka; Mitsuko Takenaga; Rie Igarashi; Taishi Maeda; Naoki Yamakawa; Yoshinari Okamoto; Masami Otsuka; Tatsuhiro Ishida; Hiroshi Kiwada; Yutaka Mizushima; Tohru Mizushima
Journal:  Pharm Res       Date:  2009-07-25       Impact factor: 4.200

4.  Synthesis of prostaglandin E(1) phosphate derivatives and their encapsulation in biodegradable nanoparticles.

Authors:  Miho Takeda; Taishi Maeda; Tsutomu Ishihara; Haruka Sakamoto; Kanae Yuki; Naoko Takasaki; Fumihiro Nishimura; Takeshi Yamashita; Ken-Ichiro Tanaka; Mitsuko Takenaga; Rie Igarashi; Megumu Higaki; Naoki Yamakawa; Yoshinari Okamoto; Hisao Ogawa; Masami Otsuka; Yutaka Mizushima; Tohru Mizushima
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

5.  Continuous infusion of lipo-prostaglandin E1 for Takayasu's arteritis with heart failure in an 11-month-old baby: a case report.

Authors:  Ryo Higaki; Aya Miyazaki; Yujiro Tajiri; Mikihito Shoji; Shun Saito; Shin-Ichiro Yoshimura; Naoki Miki; Kazuhiro Hatta; Hiraku Doi
Journal:  J Med Case Rep       Date:  2018-09-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.